Fig. 1

Virologic response and clinical course of glecaprevir and pibrentasvir therapy for HCV and hepatitis flare during R-CHOP for DLBCL. Changes in the serum hepatitis C virus (HCV) titer, alanine aminotransferase (ALT), and aspartate aminotransferase (AST) are shown. HCV, hepatitis C virus; ALT, alanine transaminase